Surge Biswas
Co- Founder & Chief Executive Officer Nabla Bio
Founder and CEO at Nabla Bio. Scientist focused on developing AI and experimental technologies to engineer biology.
Seminars
Thursday 25th June 2026
Exploring the De novo Design & Hypothesis-Driven exploration of Potent T-cell Engagers with JAM-2
10:00 am
- Exploring how generative design enables the rational construction of multispecifics
- Rapid generation of developable TCEs by designing in developability
- Exploration of new target space for TAAs including complex multipass membrane proteins
- Rationale design of TCEs that optimize the immune synapse
Thursday 25th June 2026
Roundtable Discussion: Utilizing Discovery Platforms to Hunt for the Perfect Target & Advance T-Cell Engager Efficacy in Solid & Liquid Tumors
2:30 pm
- Discussing the methodologies currently used to identify antigens in multiple myeloma and B-cell lymphoma
- Debating whether therapeutic failure in hematologic cancers stems from T-cell exhaustion or from a lack of high-density, specific antigens to target
- Identifying shared antigens vs personalized neoantigens in solid tumor populations
